新兴的治疗方法调节肠道微生物群
Ilaria Cosimato1, Annalisa Brescia2, Gianluigi Franci1,3
1Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.
Pharmaceutics
|February 27, 2026
概括
像便微生物种移植 (FMT) 和菌体疗法等新兴疗法在恢复肠道微生物平衡 (eubiosis) 和治疗与失生症相关的疾病方面表现有前途. 为了安全性和标准化,需要进一步的研究.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群显著影响宿主的新陈代谢,免疫力和疾病.
- 微生物失衡 (失生症) 与胃肠道和肠外疾病有关.
- 恢复微生物平衡 (eubiosis) 对人类健康至关重要.
研究的目的:
- 对调节肠道微生物群的新兴治疗策略进行审查.
- 探索治疗微生物群相关疾病的新方法.
主要方法:
- 临床前和临床研究的叙述性综述.
- 专注于便微生物群移植 (FMT),细菌联合体移植 (BCT),菌体治疗和外膜囊泡 (OMV).
主要成果:
- 益生菌,益生菌和协生菌显示出潜力,但取决于上下文.
- FMT对于复发性Clostridioides difficile感染是有效的,并且正在研究其他疾病.
- BCT,菌体疗法和OMVs是新兴的战略,具有早期有希望的结果.
结论:
- 新型肠道微生物群调节策略为精准医学提供了新的途径.
- 这些疗法可以彻底改变疾病的预防和治疗.
- 进一步的研究对于确保安全性,标准化和临床适用性至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
508
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
508
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
972
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
972
Bacterial Flora of the Large Intestine
1.8K
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
1.8K
Drugs for Treatment of Diarrhea-Predominant IBS
798
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
798


